167 related articles for article (PubMed ID: 27050021)
21. [Economic burden and related factors on inpatients with HBV-related diseases in Shandong province].
Lü JJ; Li RP; Xu AQ; Zhang L; Song LZ; Yan BY; Ji F; Liu JY; Fang XQ; Wang Z; Zhu DW; Zhang GJ; Feng Y; Xiao ZK; Wang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar; 34(3):267-72. PubMed ID: 23759235
[TBL] [Abstract][Full Text] [Related]
22. Health care utilization and costs in type 2 diabetes mellitus and their association with renal impairment.
Burke J; Kovacs B; Borton L; Sander S
Postgrad Med; 2012 Mar; 124(2):77-91. PubMed ID: 22437218
[TBL] [Abstract][Full Text] [Related]
23. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.
Yang J; Jit M; Leung KS; Zheng YM; Feng LZ; Wang LP; Lau EH; Wu JT; Yu HJ
Infect Dis Poverty; 2015 Oct; 4():44. PubMed ID: 26445412
[TBL] [Abstract][Full Text] [Related]
24. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
25. Wilson's Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States.
Rustgi VK; Gupta K; Tait C; Bhurwal A; Kabaria S; Catalano C; Li Y; Minacapelli CD
Hepatol Commun; 2022 Feb; 6(2):389-398. PubMed ID: 34559472
[TBL] [Abstract][Full Text] [Related]
26. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
Mast EE; Weinbaum CM; Fiore AE; Alter MJ; Bell BP; Finelli L; Rodewald LE; Douglas JM; Janssen RS; Ward JW;
MMWR Recomm Rep; 2006 Dec; 55(RR-16):1-33; quiz CE1-4. PubMed ID: 17159833
[TBL] [Abstract][Full Text] [Related]
27. How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China?
Wang W; Fu CW; Pan CY; Chen W; Zhan S; Luan R; Tan A; Liu Z; Xu B
Value Health; 2009 Sep; 12(6):923-9. PubMed ID: 19824187
[TBL] [Abstract][Full Text] [Related]
28. Cost of acute hepatitis B infection in Swedish adults.
Struve J; Giesecke J
Scand J Infect Dis; 1993; 25(6):693-7. PubMed ID: 8052808
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?
Winter RJ; Dietze PM; Gouillou M; Hellard ME; Robinson P; Aitken CK
J Gastroenterol Hepatol; 2013 Feb; 28(2):314-22. PubMed ID: 23190264
[TBL] [Abstract][Full Text] [Related]
30. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
31. Disease Burden from Hepatitis B Virus Infection in Guangdong Province, China.
Xiao J; Lin H; Liu T; Zeng W; Li X; Shao X; Tan Q; Xu Y; Xu X; Zheng H; Ma W
Int J Environ Res Public Health; 2015 Nov; 12(11):14055-67. PubMed ID: 26540065
[TBL] [Abstract][Full Text] [Related]
32. Clinical and economic burden in patients with diagnosis of peripheral arterial disease in a claims database in Japan.
Hosaka A; Miyata T; Onishi Y; Liao L; Zhang Q
Clin Ther; 2014 Aug; 36(8):1223-30, 1230.e1-4. PubMed ID: 25012730
[TBL] [Abstract][Full Text] [Related]
33. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
Köster I; Hauner H; von Ferber L
Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
[TBL] [Abstract][Full Text] [Related]
34. Healthcare resource utilization and costs in working-age patients with high-risk atherosclerotic cardiovascular disease: findings from a multi-employer claims database.
Zhao Z; Zhu Y; Fang Y; Ye W; McCollam P
J Med Econ; 2015; 18(9):655-65. PubMed ID: 25891183
[TBL] [Abstract][Full Text] [Related]
35. Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy.
Wu EQ; Forsythe A; Guérin A; Yu AP; Latremouille-Viau D; Tsaneva M
Am J Ther; 2012 Nov; 19(6):e157-66. PubMed ID: 21317625
[TBL] [Abstract][Full Text] [Related]
36. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
Vimolket T; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
[TBL] [Abstract][Full Text] [Related]
37. Accountability, utilization and providers for diabetes management in Taiwan, 2000-2009: an analysis of the National Health Insurance database.
Chang TJ; Jiang YD; Chang CH; Chung CH; Yu NC; Chuang LM
J Formos Med Assoc; 2012 Nov; 111(11):605-16. PubMed ID: 23217596
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
39. Barriers to hepatitis B vaccine coverage among healthcare workers in the Republic of Georgia: An international perspective.
Topuridze M; Butsashvili M; Kamkamidze G; Kajaia M; Morse D; McNutt LA
Infect Control Hosp Epidemiol; 2010 Feb; 31(2):158-64. PubMed ID: 20038247
[TBL] [Abstract][Full Text] [Related]
40. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
